Model
Edge
Nabriva Therapeutics
NBRVF
Filing Type
8-K
Filing Date
5/31/2023
Updated
6/1/23, 10:30 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing